Difference between revisions of "Aminocaproic acid (Amicar)"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==General information== | ==General information== | ||
Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.<ref name="insert">[http://products.hospira.com/assets/pdfs/EN-1485.pdf Aminocaproic acid (Amicar) package insert]</ref><ref>[[Media:Aminocaproicacid.pdf | Aminocaproic acid (Amicar) package insert (locally hosted backup)]]</ref><ref>[[Media:Aminocaproicacidtablets.pdf | Aminocaproic acid tablets (Amicar) package insert (locally hosted backup)]]</ref> | Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.<ref name="insert">[http://products.hospira.com/assets/pdfs/EN-1485.pdf Aminocaproic acid (Amicar) package insert]</ref><ref>[[Media:Aminocaproicacid.pdf | Aminocaproic acid (Amicar) package insert (locally hosted backup)]]</ref><ref>[[Media:Aminocaproicacidtablets.pdf | Aminocaproic acid tablets (Amicar) package insert (locally hosted backup)]]</ref> | ||
| Line 10: | Line 8: | ||
==Patient drug information== | ==Patient drug information== | ||
*[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aminocaproic-acid-patient-drug-information Aminocaproic acid (Amicar) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Generic names:''' 6-aminohexanoic acid, epsilon aminocaproic acid, ε-aminocaproic acid, ε-Ahx | ||
| + | *'''Brand name:''' Amicar | ||
==References== | ==References== | ||
| Line 15: | Line 17: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| + | [[Category:Oral medications]] | ||
| + | [[Category:Intravenous medications]] | ||
| + | |||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
[[Category:Hemostasis medications]] | [[Category:Hemostasis medications]] | ||
Revision as of 18:31, 29 October 2017
General information
Class/mechanism: Inhibits fibrinolysis by inhibiting plasminogen activators and via antiplasmin activity.[1][2][3]
Route: IV, PO
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape,UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
Also known as
- Generic names: 6-aminohexanoic acid, epsilon aminocaproic acid, ε-aminocaproic acid, ε-Ahx
- Brand name: Amicar